4//SEC Filing
Moore Kevin D 4
Accession 0001582945-20-000004
CIK 0001425627other
Filed
Jan 15, 7:00 PM ET
Accepted
Jan 16, 3:29 PM ET
Size
10.5 KB
Accession
0001582945-20-000004
Insider Transaction Report
Form 4
Moore Kevin D
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2019-12-31+800,000→ 2,400,000 total - Award
Common Stock
2019-10-31+800,000→ 800,000 total - Award
Common Stock
2019-11-30+800,000→ 1,600,000 total - Award
Common Stock Option
2019-11-22+35,200,000→ 35,200,000 totalExercise: $0.01From: 2019-12-22Exp: 2029-12-22→ Common Stock (35,200,000 underlying)
Footnotes (2)
- [F1]Under the terms of the Reporting Person's Employment Agreement as the Issuer's Chief Executive Officer, he is entitled to 800,000 shares of the Issuer's common stock on each of October 31, 2019, November 30, 2019 and December 31, 2019.
- [F2]Pursuant to the Reporting Person's Employment Agreement, he was issued a stock option to acquire 35,200,000 shares of the Issuer's common stock at $0.00792 per share. The shares vest in equal monthly installments of 977,777 shares per month for 36 months and expire ten years from the vesting date.
Documents
Issuer
TransBiotec, Inc.
CIK 0001425627
Entity typeother
Related Parties
1- filerCIK 0001793908
Filing Metadata
- Form type
- 4
- Filed
- Jan 15, 7:00 PM ET
- Accepted
- Jan 16, 3:29 PM ET
- Size
- 10.5 KB